DocMorris (ZRSEF) News Today $10.24 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock ZRSEF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period DocMorris AG (ZRSEF) Q2 2025 Earnings Call TranscriptAugust 20, 2025 | seekingalpha.comDocMorris AG (ZRSEF) (H1 2025) Earnings Call Highlights: Strong Rx Growth and Strategic Capital ...August 20, 2025 | gurufocus.comDocMorris AG Completes Successful Rights OfferingMay 21, 2025 | tipranks.comDocMorris AG Shareholders Approve CHF 200 Million Capital IncreaseMay 8, 2025 | tipranks.comDocMorris Secures CHF 200 Million for Strategic GrowthApril 10, 2025 | tipranks.comDocMorris AG (XSWX:DOCM) Full Year 2024 Earnings Call Highlights: Strong Revenue Growth and ...March 14, 2025 | gurufocus.comFull Year 2024 DocMorris AG Earnings Call TranscriptMarch 14, 2025 | gurufocus.comDocMorris AG (ZRSEF) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | seekingalpha.comBERENBERG Downgrades DocMorris (ZRSEF)January 9, 2025 | msn.comDocMorris accelerates Rx growthOctober 15, 2024 | markets.businessinsider.comDocMorris Finance B.V.SF-Wdl.-Anl. 2024(29) BondSeptember 27, 2024 | markets.businessinsider.comJD Health International Inc 06618September 19, 2024 | morningstar.comMRedcare Pharmacy N.V.: Kürzung der Guidance bei DocMorris belastet Redcare; mwb research stuft auf KAUFENAugust 28, 2024 | finanznachrichten.deWARBURG RESEARCH stuft DocMorris auf 'Hold'August 28, 2024 | finanznachrichten.deDocMorris grows in the prescription business and invests incrementally in new Rx customersAugust 20, 2024 | markets.businessinsider.comDocMorris AG (ZRSEF) Q2 2024 Earnings Call TranscriptAugust 20, 2024 | seekingalpha.comDocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025May 23, 2024 | markets.businessinsider.comDocMorris AG: Daniel Wüest becomes new CFO at DocMorrisMay 8, 2024 | markets.businessinsider.comDocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription marketApril 16, 2024 | markets.businessinsider.comDocMorris AG (ZRSEF) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | seekingalpha.comDocMorris AG reports FY results; initiates FY24 outlookMarch 21, 2024 | msn.comLeafly Holdings Inc LFLYMarch 6, 2024 | morningstar.comMDocMorris AG ZREJanuary 16, 2024 | morningstar.comMDocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer baseJanuary 16, 2024 | markets.businessinsider.comDocMorris AG DOCMJanuary 9, 2024 | morningstar.comMDocMorris N.V.January 2, 2024 | wsj.comDocMorris AG ZRSEFDecember 16, 2023 | morningstar.comMPineapple Inc PNPLDecember 8, 2023 | morningstar.comMClicks Group Ltd ADR CLCGYNovember 11, 2023 | morningstar.comMDocMorris AG GAAP EPS of CHF12.12, revenue of CHF462.9MAugust 17, 2023 | msn.comUmbenennung: Online-Apotheke Zur Rose Group wird zu Doc MorrisMay 12, 2023 | msn.comAnnual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)May 5, 2023 | markets.businessinsider.comZur Rose Group has successfully completed the sale of its Swiss business to MigrosMay 4, 2023 | markets.businessinsider.comZur Rose delays profitability break-even to 2024March 23, 2023 | news.yahoo.comZur Rose Shares Slump After Pushing Break-Even Target to 2024March 23, 2023 | marketwatch.comZur Rose Group: Ist das der Beginn einer Trendwende?February 8, 2023 | finanznachrichten.deZur Rose Group is upgraded by Deutsche Bank to a hold ratingFebruary 7, 2023 | msn.comCiti Upgrades Zur Rose Group AG to NeutralFebruary 7, 2023 | investing.comZur Rose Group verabschiedet sich vom Schweizer Markt - Aktie springt nach obenFebruary 3, 2023 | finanznachrichten.deZur Rose Group hands over successful Swiss business to Migros to focus on growth in GermanyFebruary 3, 2023 | markets.businessinsider.comZur Rose Group: Aktie reagiert mit Kurssprung auf Erhöhung der ErgebnisprognoseJanuary 19, 2023 | finanznachrichten.deOnline pharmacy Zur Rose improves 2022 core loss targetJanuary 19, 2023 | msn.comZur Rose Group: Revenue target 2022 achieved, EBITDA better than expectedJanuary 19, 2023 | markets.businessinsider.comROSEG.S - | Stock Price & Latest News | ReutersJanuary 14, 2023 | reuters.comAktuelle Empfehlungen zur ZUR ROSE AktieDecember 12, 2022 | finanznachrichten.deZur Rose Group takes next step towards profitability and further reduces complexity in GermanyNovember 24, 2022 | markets.businessinsider.comZur Rose Group announces preliminary result and extension of Tender OfferOctober 7, 2022 | uk.finance.yahoo.comZur Rose Group announces a tender offer for all of its CHF 115 million outstanding bonds due 2023September 23, 2022 | uk.news.yahoo.comZur Rose Group AG (ROSEG)September 8, 2022 | investing.comZur Rose Group AG 2022 Q2 - Results - Earnings Call PresentationAugust 19, 2022 | seekingalpha.com Get DocMorris News Delivered to You Automatically Sign up to receive the latest news and ratings for ZRSEF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZRSEF Media Mentions By Week ZRSEF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZRSEF News Sentiment▼0.000.92▲Average Medical News Sentiment ZRSEF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZRSEF Articles This Week▼00▲ZRSEF Articles Average Week Get the Latest News and Ratings for ZRSEF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for DocMorris and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ALST News Today CLCGY News Today HITIF News Today HITID News Today IWINF News Today SAEYY News Today TGIFF News Today FFNTF News Today SXTPW News Today ABSCF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ZRSEF) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocMorris AG Please log in to your account or sign up in order to add this asset to your watchlist. Share DocMorris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZRSEF Stock Alerts